ACB

Aurora Cannabis Inc.
$3.96
-0.01 (-0.25%)
Mkt Cap 250.07M
Volume 788,293
52W Range 2.56-6.36
Sector Healthcare
Beta 1.42
EPS (TTM) -1.38 USD
P/E Ratio -2.12
Revenue (TTM) 206.63M USD
Rev Growth (5Y) +3.1%
EPS Growth (5Y) +7.7%
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
23.1 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 320.59M 343.29M 270.28M 223.80M 221.34M 245.25M 268.70M 245.54M 55.20M 18.07M 1.44M 0
Net Income (121.76M) 1.59M (69.33M) (816.63M) (1.74B) (693.62M) (3.28B) (293.51M) 71.94M (12.97M) (5.72M) (9.52M)
EPS -2.15 0.03 -1.28 -8.17 -79.92 -40.92 -333.92 -36.65 18.00 -5.58 -5.32 -9.87
Free Cash Flow (36.06M) (2.85M) (85.34M) (92.52M) (142.48M) (263.66M) (690.96M) (606.43M) (218.61M) (39.10M) (8.66M) (11.16M)
FCF / Share -0.64 -0.05 -1.66 -2.87 -6.63 -15.59 -71.41 -75.73 -55.66 -18.09 -8.05 -11.57
Operating CF (13.51M) 16.00M (68.51M) (85.63M) (110.27M) (210.58M) (342.14M) (192.25M) (81.67M) (13.38M) (6.77M) (3.32M)
Total Assets 602.64M 847.77M 840.14M 926.38M 926.38M 2.72B 2.92B 5.64B 1.90B 323.82M 18.32M 13.61M
Total Debt 23.92M 103.98M 99.78M 226.41M 226.41M 399.05M 529.01M 647.29M 204.60M 64.11M 10.64M 8.42M
Cash & Equiv 112.77M 184.26M 179.53M 300.86M 300.86M 440.30M 161.49M 219.63M 90.80M 160.28M 257,975 317,831
Book Value 513.15M 563.91M 560.75M 490.67M 490.67M 2.04B 2.14B 4.40B 1.56B 219.71M 5.74M 3.86M
Return on Equity -0.24 0.00 -0.12 -1.66 -3.54 -0.34 -1.54 -0.07 0.05 -0.06 -1.00 -2.47
ACB News
Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease
Oct 08, 2026 06:09 AM · 247wallst.com
Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output
Oct 08, 2026 03:05 AM · prnewswire.com
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway
Oct 06, 2026 12:30 PM · prnewswire.com
Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
Oct 06, 2026 07:56 AM · marketbeat.com
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
Oct 05, 2026 02:11 PM · prnewswire.com
Aurora Cannabis (TSE:ACB) Shares Up 15.6% – Still a Buy?
Oct 05, 2026 09:41 AM · defenseworld.net
Aurora Cannabis Sees Unusually High Options Volume (NASDAQ:ACB)
Oct 05, 2026 07:01 AM · defenseworld.net
Curaleaf raises Aurora Cannabis offer by 25%
Oct 05, 2026 06:37 AM · proactiveinvestors.com
Comparing ProPhase Labs (NASDAQ:PRPH) and Aurora Cannabis (NASDAQ:ACB)
Oct 04, 2026 10:58 PM · defenseworld.net
Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.
Sep 26, 2026 03:15 AM · fool.com